Thompson Siegel & Walmsley LLC Eton Pharmaceuticals, Inc. Transaction History
Thompson Siegel & Walmsley LLC
- $6.01 Billion
- Q2 2025
A detailed history of Thompson Siegel & Walmsley LLC transactions in Eton Pharmaceuticals, Inc. stock. As of the latest transaction made, Thompson Siegel & Walmsley LLC holds 381,265 shares of ETON stock, worth $6.6 Million. This represents 0.09% of its overall portfolio holdings.
Number of Shares
381,265
Previous 189,863
100.81%
Holding current value
$6.6 Million
Previous $2.46 Million
120.5%
% of portfolio
0.09%
Previous 0.04%
Shares
5 transactions
Others Institutions Holding ETON
# of Institutions
85Shares Held
15MCall Options Held
242KPut Options Held
11.8K-
Opaleye Management Inc. Boston, MA2.86MShares$49.5 Million9.75% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA2.03MShares$35.2 Million2.49% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.31MShares$22.7 Million0.0% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT1.18MShares$20.4 Million0.73% of portfolio
-
Geode Capital Management, LLC Boston, MA593KShares$10.3 Million0.0% of portfolio
About Eton Pharmaceuticals, Inc.
- Ticker ETON
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 25,297,000
- Market Cap $438M
- Description
- Eton Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on developing and commercializing pharmaceutical products for rare diseases. The company offers Biorphen, a phenylephrine injection for the treatment of clinically important hypotension resulting primarily from vasodilation in the setting of anesthesia; Carglumic Acid for th...